Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
64.80
-0.68 (-1.04%)
Feb 10, 2026, 4:00 PM EST - Market closed
Bio-Techne Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,216 | 1,220 | 1,159 | 1,137 | 1,106 | 931.03 | |
Revenue Growth (YoY) | 1.64% | 5.23% | 1.97% | 2.81% | 18.75% | 26.04% |
Cost of Revenue | 405.94 | 408.52 | 385.26 | 366.49 | 347.51 | 296.62 |
Gross Profit | 809.63 | 811.12 | 773.8 | 770.22 | 758.09 | 634.42 |
Selling, General & Admin | 440.85 | 446.38 | 428.53 | 396.61 | 391.89 | 312.41 |
Research & Development | 97.98 | 99.5 | 96.66 | 92.49 | 87.14 | 70.6 |
Operating Expenses | 538.83 | 545.88 | 525.19 | 489.11 | 479.03 | 383.02 |
Operating Income | 270.81 | 265.24 | 248.61 | 281.11 | 279.06 | 251.4 |
Interest Expense | -9.29 | -8.51 | -15.74 | -11.22 | -11.31 | -13.95 |
Interest & Investment Income | 3.48 | 3.89 | 3.32 | 3.41 | 0.79 | 0.47 |
Earnings From Equity Investments | 0.92 | 0.94 | -6.84 | -1.14 | - | - |
Currency Exchange Gain (Loss) | 1.45 | 1.45 | -0.73 | 0.68 | 0.7 | -6.65 |
Other Non Operating Income (Expenses) | 1.73 | -0.49 | -0.72 | -0.52 | -0.19 | -0.57 |
EBT Excluding Unusual Items | 269.1 | 262.51 | 227.91 | 272.31 | 269.06 | 230.7 |
Merger & Restructuring Charges | -32.57 | -41.72 | -20.54 | 4.92 | 15.46 | -9.18 |
Gain (Loss) on Sale of Investments | - | - | 0.28 | 49.33 | 15.19 | -68.05 |
Asset Writedown | -80.5 | -80.5 | -21.96 | - | -18.72 | - |
Legal Settlements | -41.83 | -41.83 | -3.51 | - | - | - |
Other Unusual Items | - | - | 3.5 | 12.1 | 20.4 | -5.3 |
Pretax Income | 114.19 | 98.46 | 185.69 | 338.66 | 301.39 | 148.18 |
Income Tax Expense | 33.09 | 25.06 | 17.58 | 53.22 | 38.29 | 8.59 |
Earnings From Continuing Operations | 81.1 | 73.4 | 168.11 | 285.44 | 263.1 | 139.59 |
Minority Interest in Earnings | - | - | - | -0.18 | 8.95 | 0.83 |
Net Income | 81.1 | 73.4 | 168.11 | 285.26 | 272.05 | 140.41 |
Preferred Dividends & Other Adjustments | 0.04 | 0.04 | 0.03 | 0.07 | 0.12 | 0.09 |
Net Income to Common | 81.06 | 73.36 | 168.07 | 285.19 | 271.93 | 140.32 |
Net Income Growth | -48.71% | -56.34% | -41.07% | 4.86% | 93.75% | -38.77% |
Shares Outstanding (Basic) | 156 | 158 | 158 | 157 | 157 | 155 |
Shares Outstanding (Diluted) | 157 | 160 | 161 | 162 | 164 | 162 |
Shares Change (YoY) | -2.20% | -0.66% | -0.67% | -1.38% | 1.35% | 2.75% |
EPS (Basic) | 0.52 | 0.47 | 1.07 | 1.81 | 1.73 | 0.91 |
EPS (Diluted) | 0.52 | 0.46 | 1.05 | 1.76 | 1.66 | 0.87 |
EPS Growth | -47.00% | -56.19% | -40.34% | 6.02% | 90.81% | -40.21% |
Free Cash Flow | 223.02 | 256.55 | 236.1 | 216.15 | 280.36 | 307.86 |
Free Cash Flow Per Share | 1.42 | 1.61 | 1.47 | 1.33 | 1.71 | 1.90 |
Dividend Per Share | 0.320 | 0.320 | 0.320 | 0.320 | 0.320 | 0.320 |
Gross Margin | 66.61% | 66.51% | 66.76% | 67.76% | 68.57% | 68.14% |
Operating Margin | 22.28% | 21.75% | 21.45% | 24.73% | 25.24% | 27.00% |
Profit Margin | 6.67% | 6.02% | 14.50% | 25.09% | 24.60% | 15.07% |
Free Cash Flow Margin | 18.35% | 21.04% | 20.37% | 19.02% | 25.36% | 33.07% |
EBITDA | 330.54 | 331.14 | 313.72 | 344.05 | 339.53 | 302.65 |
EBITDA Margin | 27.19% | 27.15% | 27.07% | 30.27% | 30.71% | 32.51% |
D&A For EBITDA | 59.73 | 65.9 | 65.11 | 62.94 | 60.47 | 51.25 |
EBIT | 270.81 | 265.24 | 248.61 | 281.11 | 279.06 | 251.4 |
EBIT Margin | 22.28% | 21.75% | 21.45% | 24.73% | 25.24% | 27.00% |
Effective Tax Rate | 28.98% | 25.45% | 9.47% | 15.71% | 12.70% | 5.80% |
Advertising Expenses | - | 3.2 | 4.1 | 4.8 | 4.6 | 4.7 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.